nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—CYP3A7—Ifosfamide—testicular cancer	0.0987	0.119	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0987	0.119	CbGbCtD
Propranolol—SLC22A2—Vinblastine—testicular cancer	0.096	0.116	CbGbCtD
Propranolol—SLC22A2—Cisplatin—testicular cancer	0.088	0.106	CbGbCtD
Propranolol—CYP3A5—Ifosfamide—testicular cancer	0.074	0.0895	CbGbCtD
Propranolol—CYP2C19—Ifosfamide—testicular cancer	0.0597	0.0722	CbGbCtD
Propranolol—ABCB1—Dactinomycin—testicular cancer	0.0408	0.0493	CbGbCtD
Propranolol—CYP3A5—Etoposide—testicular cancer	0.0354	0.0428	CbGbCtD
Propranolol—CYP3A4—Ifosfamide—testicular cancer	0.0289	0.0349	CbGbCtD
Propranolol—CYP1A2—Etoposide—testicular cancer	0.0263	0.0318	CbGbCtD
Propranolol—ABCB1—Vinblastine—testicular cancer	0.0256	0.0309	CbGbCtD
Propranolol—CYP2D6—Vinblastine—testicular cancer	0.0241	0.0291	CbGbCtD
Propranolol—ABCB1—Cisplatin—testicular cancer	0.0234	0.0283	CbGbCtD
Propranolol—ABCB1—Etoposide—testicular cancer	0.023	0.0278	CbGbCtD
Propranolol—ABCB1—Doxorubicin—testicular cancer	0.0157	0.019	CbGbCtD
Propranolol—CYP3A4—Vinblastine—testicular cancer	0.0153	0.0185	CbGbCtD
Propranolol—ABCB1—Methotrexate—testicular cancer	0.0152	0.0184	CbGbCtD
Propranolol—CYP2D6—Doxorubicin—testicular cancer	0.0148	0.0179	CbGbCtD
Propranolol—CYP3A4—Etoposide—testicular cancer	0.0138	0.0167	CbGbCtD
Propranolol—CYP3A4—Doxorubicin—testicular cancer	0.00941	0.0114	CbGbCtD
Propranolol—Nervous system disorder—Ifosfamide—testicular cancer	0.000485	0.0028	CcSEcCtD
Propranolol—Skin disorder—Ifosfamide—testicular cancer	0.000481	0.00277	CcSEcCtD
Propranolol—Vomiting—Chlorambucil—testicular cancer	0.000476	0.00274	CcSEcCtD
Propranolol—Dermatitis exfoliative—Epirubicin—testicular cancer	0.000472	0.00273	CcSEcCtD
Propranolol—Decreased appetite—Dactinomycin—testicular cancer	0.00047	0.00271	CcSEcCtD
Propranolol—Diarrhoea—Vinblastine—testicular cancer	0.000469	0.00271	CcSEcCtD
Propranolol—Fatigue—Dactinomycin—testicular cancer	0.000466	0.00269	CcSEcCtD
Propranolol—Purpura—Epirubicin—testicular cancer	0.000463	0.00267	CcSEcCtD
Propranolol—Pain—Dactinomycin—testicular cancer	0.000462	0.00266	CcSEcCtD
Propranolol—Vascular purpura—Doxorubicin—testicular cancer	0.000461	0.00266	CcSEcCtD
Propranolol—Anaphylactoid reaction—Epirubicin—testicular cancer	0.000461	0.00266	CcSEcCtD
Propranolol—Urticaria—Bleomycin—testicular cancer	0.00046	0.00265	CcSEcCtD
Propranolol—Body temperature increased—Bleomycin—testicular cancer	0.000458	0.00264	CcSEcCtD
Propranolol—Hypoglycaemia—Epirubicin—testicular cancer	0.000457	0.00264	CcSEcCtD
Propranolol—Lethargy—Epirubicin—testicular cancer	0.000455	0.00262	CcSEcCtD
Propranolol—Cardiac failure congestive—Doxorubicin—testicular cancer	0.000455	0.00262	CcSEcCtD
Propranolol—Irritability—Methotrexate—testicular cancer	0.000455	0.00262	CcSEcCtD
Propranolol—Dizziness—Vinblastine—testicular cancer	0.000453	0.00262	CcSEcCtD
Propranolol—Convulsion—Cisplatin—testicular cancer	0.000453	0.00261	CcSEcCtD
Propranolol—Mood swings—Methotrexate—testicular cancer	0.000451	0.0026	CcSEcCtD
Propranolol—Nausea—Chlorambucil—testicular cancer	0.000444	0.00256	CcSEcCtD
Propranolol—Paraesthesia—Ifosfamide—testicular cancer	0.000444	0.00256	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000442	0.00255	CcSEcCtD
Propranolol—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000442	0.00255	CcSEcCtD
Propranolol—Dyspnoea—Ifosfamide—testicular cancer	0.000441	0.00255	CcSEcCtD
Propranolol—Somnolence—Ifosfamide—testicular cancer	0.00044	0.00254	CcSEcCtD
Propranolol—Affect lability—Epirubicin—testicular cancer	0.000439	0.00253	CcSEcCtD
Propranolol—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.000437	0.00252	CcSEcCtD
Propranolol—Vomiting—Vinblastine—testicular cancer	0.000436	0.00251	CcSEcCtD
Propranolol—Vertigo—Etoposide—testicular cancer	0.00043	0.00248	CcSEcCtD
Propranolol—Decreased appetite—Ifosfamide—testicular cancer	0.00043	0.00248	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000429	0.00247	CcSEcCtD
Propranolol—Purpura—Doxorubicin—testicular cancer	0.000428	0.00247	CcSEcCtD
Propranolol—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000427	0.00246	CcSEcCtD
Propranolol—Abdominal pain—Dactinomycin—testicular cancer	0.000427	0.00246	CcSEcCtD
Propranolol—Body temperature increased—Dactinomycin—testicular cancer	0.000427	0.00246	CcSEcCtD
Propranolol—Fatigue—Ifosfamide—testicular cancer	0.000427	0.00246	CcSEcCtD
Propranolol—Anaphylactic shock—Cisplatin—testicular cancer	0.000427	0.00246	CcSEcCtD
Propranolol—Hypersensitivity—Bleomycin—testicular cancer	0.000427	0.00246	CcSEcCtD
Propranolol—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000426	0.00246	CcSEcCtD
Propranolol—Cardiac arrest—Epirubicin—testicular cancer	0.000424	0.00245	CcSEcCtD
Propranolol—Infection—Cisplatin—testicular cancer	0.000424	0.00245	CcSEcCtD
Propranolol—Constipation—Ifosfamide—testicular cancer	0.000423	0.00244	CcSEcCtD
Propranolol—Pain—Ifosfamide—testicular cancer	0.000423	0.00244	CcSEcCtD
Propranolol—Hypoglycaemia—Doxorubicin—testicular cancer	0.000423	0.00244	CcSEcCtD
Propranolol—Mood swings—Epirubicin—testicular cancer	0.000422	0.00244	CcSEcCtD
Propranolol—Lethargy—Doxorubicin—testicular cancer	0.000421	0.00243	CcSEcCtD
Propranolol—Nervous system disorder—Cisplatin—testicular cancer	0.000418	0.00241	CcSEcCtD
Propranolol—Cough—Etoposide—testicular cancer	0.000418	0.00241	CcSEcCtD
Propranolol—Asthenia—Bleomycin—testicular cancer	0.000416	0.0024	CcSEcCtD
Propranolol—Convulsion—Etoposide—testicular cancer	0.000415	0.00239	CcSEcCtD
Propranolol—Skin disorder—Cisplatin—testicular cancer	0.000414	0.00239	CcSEcCtD
Propranolol—Nausea—Vinblastine—testicular cancer	0.000407	0.00235	CcSEcCtD
Propranolol—Affect lability—Doxorubicin—testicular cancer	0.000406	0.00234	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000405	0.00234	CcSEcCtD
Propranolol—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000405	0.00233	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000401	0.00232	CcSEcCtD
Propranolol—Hypersensitivity—Dactinomycin—testicular cancer	0.000398	0.0023	CcSEcCtD
Propranolol—Urticaria—Ifosfamide—testicular cancer	0.000393	0.00227	CcSEcCtD
Propranolol—Cardiac arrest—Doxorubicin—testicular cancer	0.000392	0.00226	CcSEcCtD
Propranolol—Body temperature increased—Ifosfamide—testicular cancer	0.000391	0.00226	CcSEcCtD
Propranolol—Abdominal pain—Ifosfamide—testicular cancer	0.000391	0.00226	CcSEcCtD
Propranolol—Anaphylactic shock—Etoposide—testicular cancer	0.000391	0.00225	CcSEcCtD
Propranolol—Mood swings—Doxorubicin—testicular cancer	0.000391	0.00225	CcSEcCtD
Propranolol—Infection—Etoposide—testicular cancer	0.000388	0.00224	CcSEcCtD
Propranolol—Asthenia—Dactinomycin—testicular cancer	0.000388	0.00224	CcSEcCtD
Propranolol—Neutropenia—Methotrexate—testicular cancer	0.000385	0.00222	CcSEcCtD
Propranolol—Paraesthesia—Cisplatin—testicular cancer	0.000383	0.00221	CcSEcCtD
Propranolol—Dyspnoea—Cisplatin—testicular cancer	0.00038	0.00219	CcSEcCtD
Propranolol—Skin disorder—Etoposide—testicular cancer	0.00038	0.00219	CcSEcCtD
Propranolol—Erectile dysfunction—Methotrexate—testicular cancer	0.000379	0.00219	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000371	0.00214	CcSEcCtD
Propranolol—Decreased appetite—Cisplatin—testicular cancer	0.000371	0.00214	CcSEcCtD
Propranolol—Bronchitis—Epirubicin—testicular cancer	0.000371	0.00214	CcSEcCtD
Propranolol—Diarrhoea—Dactinomycin—testicular cancer	0.00037	0.00213	CcSEcCtD
Propranolol—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000368	0.00212	CcSEcCtD
Propranolol—Vomiting—Bleomycin—testicular cancer	0.000368	0.00212	CcSEcCtD
Propranolol—Infestation—Methotrexate—testicular cancer	0.000367	0.00212	CcSEcCtD
Propranolol—Infestation NOS—Methotrexate—testicular cancer	0.000367	0.00212	CcSEcCtD
Propranolol—Depression—Methotrexate—testicular cancer	0.000366	0.00211	CcSEcCtD
Propranolol—Rash—Bleomycin—testicular cancer	0.000365	0.00211	CcSEcCtD
Propranolol—Pain—Cisplatin—testicular cancer	0.000365	0.0021	CcSEcCtD
Propranolol—Dermatitis—Bleomycin—testicular cancer	0.000365	0.0021	CcSEcCtD
Propranolol—Hypersensitivity—Ifosfamide—testicular cancer	0.000365	0.0021	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000364	0.0021	CcSEcCtD
Propranolol—Neutropenia—Epirubicin—testicular cancer	0.00036	0.00208	CcSEcCtD
Propranolol—Asthenia—Ifosfamide—testicular cancer	0.000355	0.00205	CcSEcCtD
Propranolol—Paraesthesia—Etoposide—testicular cancer	0.000351	0.00202	CcSEcCtD
Propranolol—Dyspnoea—Etoposide—testicular cancer	0.000349	0.00201	CcSEcCtD
Propranolol—Somnolence—Etoposide—testicular cancer	0.000348	0.002	CcSEcCtD
Propranolol—Nausea—Bleomycin—testicular cancer	0.000344	0.00198	CcSEcCtD
Propranolol—Infestation NOS—Epirubicin—testicular cancer	0.000344	0.00198	CcSEcCtD
Propranolol—Infestation—Epirubicin—testicular cancer	0.000344	0.00198	CcSEcCtD
Propranolol—Vomiting—Dactinomycin—testicular cancer	0.000343	0.00198	CcSEcCtD
Propranolol—Bronchitis—Doxorubicin—testicular cancer	0.000343	0.00198	CcSEcCtD
Propranolol—Agranulocytosis—Methotrexate—testicular cancer	0.000343	0.00198	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000341	0.00196	CcSEcCtD
Propranolol—Rash—Dactinomycin—testicular cancer	0.000341	0.00196	CcSEcCtD
Propranolol—Decreased appetite—Etoposide—testicular cancer	0.00034	0.00196	CcSEcCtD
Propranolol—Diarrhoea—Ifosfamide—testicular cancer	0.000339	0.00195	CcSEcCtD
Propranolol—Gastrointestinal disorder—Etoposide—testicular cancer	0.000337	0.00195	CcSEcCtD
Propranolol—Body temperature increased—Cisplatin—testicular cancer	0.000337	0.00195	CcSEcCtD
Propranolol—Fatigue—Etoposide—testicular cancer	0.000337	0.00194	CcSEcCtD
Propranolol—Constipation—Etoposide—testicular cancer	0.000334	0.00193	CcSEcCtD
Propranolol—Pain—Etoposide—testicular cancer	0.000334	0.00193	CcSEcCtD
Propranolol—Neutropenia—Doxorubicin—testicular cancer	0.000333	0.00192	CcSEcCtD
Propranolol—Dizziness—Ifosfamide—testicular cancer	0.000327	0.00189	CcSEcCtD
Propranolol—Pharyngitis—Methotrexate—testicular cancer	0.000327	0.00189	CcSEcCtD
Propranolol—Nausea—Dactinomycin—testicular cancer	0.000321	0.00185	CcSEcCtD
Propranolol—Agranulocytosis—Epirubicin—testicular cancer	0.000321	0.00185	CcSEcCtD
Propranolol—Gastrointestinal pain—Etoposide—testicular cancer	0.00032	0.00184	CcSEcCtD
Propranolol—Infestation NOS—Doxorubicin—testicular cancer	0.000318	0.00183	CcSEcCtD
Propranolol—Infestation—Doxorubicin—testicular cancer	0.000318	0.00183	CcSEcCtD
Propranolol—Visual impairment—Methotrexate—testicular cancer	0.000318	0.00183	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000315	0.00182	CcSEcCtD
Propranolol—Vomiting—Ifosfamide—testicular cancer	0.000315	0.00182	CcSEcCtD
Propranolol—Hypersensitivity—Cisplatin—testicular cancer	0.000314	0.00181	CcSEcCtD
Propranolol—Bradycardia—Epirubicin—testicular cancer	0.000314	0.00181	CcSEcCtD
Propranolol—Rash—Ifosfamide—testicular cancer	0.000312	0.0018	CcSEcCtD
Propranolol—Dermatitis—Ifosfamide—testicular cancer	0.000312	0.0018	CcSEcCtD
Propranolol—Erythema multiforme—Methotrexate—testicular cancer	0.000312	0.0018	CcSEcCtD
Propranolol—Urticaria—Etoposide—testicular cancer	0.000311	0.00179	CcSEcCtD
Propranolol—Abdominal pain—Etoposide—testicular cancer	0.000309	0.00178	CcSEcCtD
Propranolol—Body temperature increased—Etoposide—testicular cancer	0.000309	0.00178	CcSEcCtD
Propranolol—Asthenia—Cisplatin—testicular cancer	0.000306	0.00177	CcSEcCtD
Propranolol—Pharyngitis—Epirubicin—testicular cancer	0.000306	0.00177	CcSEcCtD
Propranolol—Cardiac disorder—Methotrexate—testicular cancer	0.000306	0.00176	CcSEcCtD
Propranolol—Visual impairment—Epirubicin—testicular cancer	0.000297	0.00171	CcSEcCtD
Propranolol—Agranulocytosis—Doxorubicin—testicular cancer	0.000297	0.00171	CcSEcCtD
Propranolol—Nausea—Ifosfamide—testicular cancer	0.000294	0.0017	CcSEcCtD
Propranolol—Diarrhoea—Cisplatin—testicular cancer	0.000292	0.00168	CcSEcCtD
Propranolol—Erythema multiforme—Epirubicin—testicular cancer	0.000292	0.00168	CcSEcCtD
Propranolol—Alopecia—Methotrexate—testicular cancer	0.000291	0.00168	CcSEcCtD
Propranolol—Bradycardia—Doxorubicin—testicular cancer	0.000291	0.00168	CcSEcCtD
Propranolol—Mental disorder—Methotrexate—testicular cancer	0.000289	0.00167	CcSEcCtD
Propranolol—Hypersensitivity—Etoposide—testicular cancer	0.000288	0.00166	CcSEcCtD
Propranolol—Erythema—Methotrexate—testicular cancer	0.000287	0.00165	CcSEcCtD
Propranolol—Cardiac disorder—Epirubicin—testicular cancer	0.000286	0.00165	CcSEcCtD
Propranolol—Pharyngitis—Doxorubicin—testicular cancer	0.000283	0.00163	CcSEcCtD
Propranolol—Asthenia—Etoposide—testicular cancer	0.00028	0.00162	CcSEcCtD
Propranolol—Visual impairment—Doxorubicin—testicular cancer	0.000275	0.00159	CcSEcCtD
Propranolol—Alopecia—Epirubicin—testicular cancer	0.000273	0.00157	CcSEcCtD
Propranolol—Vomiting—Cisplatin—testicular cancer	0.000271	0.00156	CcSEcCtD
Propranolol—Mental disorder—Epirubicin—testicular cancer	0.00027	0.00156	CcSEcCtD
Propranolol—Erythema multiforme—Doxorubicin—testicular cancer	0.00027	0.00156	CcSEcCtD
Propranolol—Rash—Cisplatin—testicular cancer	0.000269	0.00155	CcSEcCtD
Propranolol—Dermatitis—Cisplatin—testicular cancer	0.000269	0.00155	CcSEcCtD
Propranolol—Erythema—Epirubicin—testicular cancer	0.000268	0.00155	CcSEcCtD
Propranolol—Diarrhoea—Etoposide—testicular cancer	0.000267	0.00154	CcSEcCtD
Propranolol—Cardiac disorder—Doxorubicin—testicular cancer	0.000265	0.00153	CcSEcCtD
Propranolol—Dizziness—Etoposide—testicular cancer	0.000258	0.00149	CcSEcCtD
Propranolol—Vertigo—Methotrexate—testicular cancer	0.000258	0.00149	CcSEcCtD
Propranolol—Nausea—Cisplatin—testicular cancer	0.000253	0.00146	CcSEcCtD
Propranolol—Alopecia—Doxorubicin—testicular cancer	0.000252	0.00145	CcSEcCtD
Propranolol—Cough—Methotrexate—testicular cancer	0.00025	0.00144	CcSEcCtD
Propranolol—Mental disorder—Doxorubicin—testicular cancer	0.00025	0.00144	CcSEcCtD
Propranolol—Convulsion—Methotrexate—testicular cancer	0.000249	0.00143	CcSEcCtD
Propranolol—Vomiting—Etoposide—testicular cancer	0.000249	0.00143	CcSEcCtD
Propranolol—Erythema—Doxorubicin—testicular cancer	0.000248	0.00143	CcSEcCtD
Propranolol—Agitation—Epirubicin—testicular cancer	0.000247	0.00142	CcSEcCtD
Propranolol—Rash—Etoposide—testicular cancer	0.000246	0.00142	CcSEcCtD
Propranolol—Dermatitis—Etoposide—testicular cancer	0.000246	0.00142	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000243	0.0014	CcSEcCtD
Propranolol—Vertigo—Epirubicin—testicular cancer	0.000241	0.00139	CcSEcCtD
Propranolol—Cough—Epirubicin—testicular cancer	0.000234	0.00135	CcSEcCtD
Propranolol—Anaphylactic shock—Methotrexate—testicular cancer	0.000234	0.00135	CcSEcCtD
Propranolol—Convulsion—Epirubicin—testicular cancer	0.000233	0.00134	CcSEcCtD
Propranolol—Infection—Methotrexate—testicular cancer	0.000233	0.00134	CcSEcCtD
Propranolol—Nausea—Etoposide—testicular cancer	0.000232	0.00134	CcSEcCtD
Propranolol—Nervous system disorder—Methotrexate—testicular cancer	0.00023	0.00132	CcSEcCtD
Propranolol—Agitation—Doxorubicin—testicular cancer	0.000228	0.00132	CcSEcCtD
Propranolol—Skin disorder—Methotrexate—testicular cancer	0.000227	0.00131	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000227	0.00131	CcSEcCtD
Propranolol—Vertigo—Doxorubicin—testicular cancer	0.000223	0.00129	CcSEcCtD
Propranolol—Anaphylactic shock—Epirubicin—testicular cancer	0.000219	0.00126	CcSEcCtD
Propranolol—Infection—Epirubicin—testicular cancer	0.000218	0.00126	CcSEcCtD
Propranolol—Cough—Doxorubicin—testicular cancer	0.000217	0.00125	CcSEcCtD
Propranolol—Convulsion—Doxorubicin—testicular cancer	0.000215	0.00124	CcSEcCtD
Propranolol—Nervous system disorder—Epirubicin—testicular cancer	0.000215	0.00124	CcSEcCtD
Propranolol—Skin disorder—Epirubicin—testicular cancer	0.000213	0.00123	CcSEcCtD
Propranolol—Insomnia—Methotrexate—testicular cancer	0.000212	0.00122	CcSEcCtD
Propranolol—Paraesthesia—Methotrexate—testicular cancer	0.00021	0.00121	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00021	0.00121	CcSEcCtD
Propranolol—Dyspnoea—Methotrexate—testicular cancer	0.000209	0.0012	CcSEcCtD
Propranolol—Somnolence—Methotrexate—testicular cancer	0.000208	0.0012	CcSEcCtD
Propranolol—Dyspepsia—Methotrexate—testicular cancer	0.000206	0.00119	CcSEcCtD
Propranolol—Decreased appetite—Methotrexate—testicular cancer	0.000204	0.00117	CcSEcCtD
Propranolol—Anaphylactic shock—Doxorubicin—testicular cancer	0.000203	0.00117	CcSEcCtD
Propranolol—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000202	0.00117	CcSEcCtD
Propranolol—Fatigue—Methotrexate—testicular cancer	0.000202	0.00116	CcSEcCtD
Propranolol—Infection—Doxorubicin—testicular cancer	0.000201	0.00116	CcSEcCtD
Propranolol—Pain—Methotrexate—testicular cancer	0.0002	0.00115	CcSEcCtD
Propranolol—Nervous system disorder—Doxorubicin—testicular cancer	0.000199	0.00115	CcSEcCtD
Propranolol—Insomnia—Epirubicin—testicular cancer	0.000198	0.00114	CcSEcCtD
Propranolol—Skin disorder—Doxorubicin—testicular cancer	0.000197	0.00114	CcSEcCtD
Propranolol—Paraesthesia—Epirubicin—testicular cancer	0.000197	0.00113	CcSEcCtD
Propranolol—Dyspnoea—Epirubicin—testicular cancer	0.000195	0.00113	CcSEcCtD
Propranolol—Somnolence—Epirubicin—testicular cancer	0.000195	0.00112	CcSEcCtD
Propranolol—Dyspepsia—Epirubicin—testicular cancer	0.000193	0.00111	CcSEcCtD
Propranolol—Gastrointestinal pain—Methotrexate—testicular cancer	0.000191	0.0011	CcSEcCtD
Propranolol—Decreased appetite—Epirubicin—testicular cancer	0.00019	0.0011	CcSEcCtD
Propranolol—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000189	0.00109	CcSEcCtD
Propranolol—Fatigue—Epirubicin—testicular cancer	0.000189	0.00109	CcSEcCtD
Propranolol—Pain—Epirubicin—testicular cancer	0.000187	0.00108	CcSEcCtD
Propranolol—Constipation—Epirubicin—testicular cancer	0.000187	0.00108	CcSEcCtD
Propranolol—Urticaria—Methotrexate—testicular cancer	0.000186	0.00107	CcSEcCtD
Propranolol—Abdominal pain—Methotrexate—testicular cancer	0.000185	0.00107	CcSEcCtD
Propranolol—Body temperature increased—Methotrexate—testicular cancer	0.000185	0.00107	CcSEcCtD
Propranolol—Insomnia—Doxorubicin—testicular cancer	0.000183	0.00106	CcSEcCtD
Propranolol—Paraesthesia—Doxorubicin—testicular cancer	0.000182	0.00105	CcSEcCtD
Propranolol—Dyspnoea—Doxorubicin—testicular cancer	0.000181	0.00104	CcSEcCtD
Propranolol—Somnolence—Doxorubicin—testicular cancer	0.00018	0.00104	CcSEcCtD
Propranolol—Gastrointestinal pain—Epirubicin—testicular cancer	0.000179	0.00103	CcSEcCtD
Propranolol—Dyspepsia—Doxorubicin—testicular cancer	0.000178	0.00103	CcSEcCtD
Propranolol—Decreased appetite—Doxorubicin—testicular cancer	0.000176	0.00102	CcSEcCtD
Propranolol—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000175	0.00101	CcSEcCtD
Propranolol—Fatigue—Doxorubicin—testicular cancer	0.000175	0.00101	CcSEcCtD
Propranolol—Urticaria—Epirubicin—testicular cancer	0.000174	0.001	CcSEcCtD
Propranolol—Pain—Doxorubicin—testicular cancer	0.000173	0.001	CcSEcCtD
Propranolol—Constipation—Doxorubicin—testicular cancer	0.000173	0.001	CcSEcCtD
Propranolol—Abdominal pain—Epirubicin—testicular cancer	0.000173	0.000999	CcSEcCtD
Propranolol—Body temperature increased—Epirubicin—testicular cancer	0.000173	0.000999	CcSEcCtD
Propranolol—Hypersensitivity—Methotrexate—testicular cancer	0.000173	0.000995	CcSEcCtD
Propranolol—Asthenia—Methotrexate—testicular cancer	0.000168	0.000969	CcSEcCtD
Propranolol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000166	0.000956	CcSEcCtD
Propranolol—Hypersensitivity—Epirubicin—testicular cancer	0.000161	0.000931	CcSEcCtD
Propranolol—Urticaria—Doxorubicin—testicular cancer	0.000161	0.000929	CcSEcCtD
Propranolol—Abdominal pain—Doxorubicin—testicular cancer	0.00016	0.000924	CcSEcCtD
Propranolol—Body temperature increased—Doxorubicin—testicular cancer	0.00016	0.000924	CcSEcCtD
Propranolol—Diarrhoea—Methotrexate—testicular cancer	0.00016	0.000924	CcSEcCtD
Propranolol—Asthenia—Epirubicin—testicular cancer	0.000157	0.000907	CcSEcCtD
Propranolol—Dizziness—Methotrexate—testicular cancer	0.000155	0.000893	CcSEcCtD
Propranolol—Diarrhoea—Epirubicin—testicular cancer	0.00015	0.000865	CcSEcCtD
Propranolol—Hypersensitivity—Doxorubicin—testicular cancer	0.000149	0.000862	CcSEcCtD
Propranolol—Vomiting—Methotrexate—testicular cancer	0.000149	0.000859	CcSEcCtD
Propranolol—Rash—Methotrexate—testicular cancer	0.000148	0.000852	CcSEcCtD
Propranolol—Dermatitis—Methotrexate—testicular cancer	0.000147	0.000851	CcSEcCtD
Propranolol—Asthenia—Doxorubicin—testicular cancer	0.000145	0.000839	CcSEcCtD
Propranolol—Dizziness—Epirubicin—testicular cancer	0.000145	0.000836	CcSEcCtD
Propranolol—Vomiting—Epirubicin—testicular cancer	0.000139	0.000804	CcSEcCtD
Propranolol—Nausea—Methotrexate—testicular cancer	0.000139	0.000802	CcSEcCtD
Propranolol—Diarrhoea—Doxorubicin—testicular cancer	0.000139	0.0008	CcSEcCtD
Propranolol—Rash—Epirubicin—testicular cancer	0.000138	0.000797	CcSEcCtD
Propranolol—Dermatitis—Epirubicin—testicular cancer	0.000138	0.000796	CcSEcCtD
Propranolol—Dizziness—Doxorubicin—testicular cancer	0.000134	0.000773	CcSEcCtD
Propranolol—Nausea—Epirubicin—testicular cancer	0.00013	0.000751	CcSEcCtD
Propranolol—Vomiting—Doxorubicin—testicular cancer	0.000129	0.000744	CcSEcCtD
Propranolol—Rash—Doxorubicin—testicular cancer	0.000128	0.000737	CcSEcCtD
Propranolol—Dermatitis—Doxorubicin—testicular cancer	0.000128	0.000737	CcSEcCtD
Propranolol—Nausea—Doxorubicin—testicular cancer	0.00012	0.000695	CcSEcCtD
